NCT01883284View on ClinicalTrials.gov

Action of Epigenetic Modifiers in Cystic Fibrosis Treatment

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Cystic FibrosisHealthy Subjects
Interventions
OTHER

Tests in vitro after sampling nasal cells of CF patients or controls

Nasal cells of CF patients or controls were collected by scratching of intermediate turbinate and cultured in vitro. Epigenetic modifiers treatment was applied to these ex vivo nasal epithelia. Then, mRNA, protein and secretions were quantified.

Trial Locations (1)

34295

Respiratory Diseases Department, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT01883284 - Action of Epigenetic Modifiers in Cystic Fibrosis Treatment | Biotech Hunter | Biotech Hunter